TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

BioSante Pharmaceuticals, Inc. Faces Investor Investigations Over LibiGel Efficacy Trial Results

  • If you purchased shares of BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), you may have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

San Diego, Jan. 10, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in shares of BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) over potential securities laws violations by certain officers and directors at Bio Sante Pharmaceuticals in connection with the efficacy trial results for its LibiGel was announced. The investigation by a law firm focuses on possible ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: